CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > Sexual Health   
Sexual Health
Journal Banner
  Publishing on sexual health from the widest perspective
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
About the Journal
Editorial Committee
Contacts
Content
Online Early
Current Issue
Just Accepted
All Issues
Online Early
Special Issues
Sample Issue
For Authors
General Information
Instructions to Authors
Submit Article
Open Access
For Referees
Referee Guidelines
Review Article
Annual Referee Index
For Advertisers
For Subscribers
Subscription Prices
Customer Service
Print Publication Dates

blue arrow e-Alerts
blank image
Subscribe to our Email Alert or RSS feeds for the latest journal papers.

red arrow Connect with us
blank image
facebook   youtube

red arrow Interview with Kit Fairley
blank image
Hear Kit Fairley speak about what is sexual health.

 
Table of Contents << Previous Issue     |     Next Issue >>  

Sexual Health Sexual Health
Volume 7 Number 3 2010
Human papillomavirus


Descriptive Table of Contents 


pp. i-iv

 


Advancements in the control of genital human papillomavirus infections and related diseases: highlighting Australia's role 

Suzanne M. Garland, Julia M. L. Brotherton, Christopher K. Fairley, Dorota M. Gertig and Marion Saville

pp. 227-229

 


Cervical cancer vaccine development 

Ian H. Frazer

pp. 230-234

  
 


For debate: that Australia should continue using the quadrivalent vaccine 

Gerard Wain

pp. 235-237

  
 


For debate: that Australia should consider changing to the bivalent vaccine 

Peter L. Stern

pp. 238-241

  
 


Commentary on opinion pieces re Australian human papillomavirus vaccine policy 

Peter McIntyre

pp. 242-243

 


Cancers attributable to human papillomavirus infection 

Andrew E. Grulich, Fengyi Jin, E. Lynne Conway, Alicia N. Stein and Jane Hocking

pp. 244-252

 


Estimating the prevalence of and treatment patterns for juvenile onset recurrent respiratory papillomatosis in Australia pre-vaccination: a pilot study 

Daniel Novakovic, Alan T. L. Cheng, Daron H. Cope and Julia M. L. Brotherton

pp. 253-261

  
 


Human papillomavirus vaccine introduction in Vietnam: formative research findings 

Nguyen Quy Nghi, D. Scott LaMontagne, Allison Bingham, Mirriam Rafiq, Le Thi Phuong Mai, Nguyen Thi Phuong Lien, Nguyen Cong Khanh, Duong Thi Hong, Dang Thi Thanh Huyen, Nguyen Thi Thi Tho and Nguyen Tran Hien

pp. 262-270

  
 


'It's a logistical nightmare!' Recommendations for optimising human papillomavirus school-based vaccination experience 

Spring Chenoa Cooper Robbins, Diana Bernard, Kirsten McCaffery and S. Rachel Skinner

pp. 271-278

  
 


Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence 

Ingrid T. Katz, Norma C. Ware, Glenda Gray, Jessica E. Haberer, Claude A. Mellins and David R. Bangsberg

pp. 279-286

  
 


Low rates of free human papillomavirus vaccine uptake among young women 

Gregory R. Moore, Richard A. Crosby, April Young and Richard Charnigo

pp. 287-290

  
 


National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program 

Julia M. L. Brotherton, Julie Leask, Cath Jackson, Kirsten McCaffery and Lyndal J. Trevena

pp. 291-298

  
 


Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women 

Marian K. Pitts, Wendy Heywood, Richard Ryall, Anthony M. Smith, Julia M. Shelley, Juliet Richters and Judy M. Simpson

pp. 299-303

  
 


Human papillomavirus vaccine acceptability among a national sample of adult women in the USA 

Nathan W. Stupiansky, Susan L. Rosenthal, Sarah E. Wiehe and Gregory D. Zimet

pp. 304-309

  
 


Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy 

Julia M. L. Brotherton, John M. Kaldor and Suzanne M. Garland

pp. 310-319

 


Human papillomavirus vaccine safety in Australia: experience to date and issues for surveillance 

Michael S. Gold, Jim Buttery and Peter McIntyre

pp. 320-324

  
 


What can surveillance of genital warts tell us? 

Christopher K. Fairley and Basil Donovan

pp. 325-327

  
 


Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination 

Alison C. Budd and Christine J. Sturrock

pp. 328-334

  
 


Quality assessment for human papillomavirus testing 

Sepehr N. Tabrizi

pp. 335-337

 


US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening 

Charlene Wong, Zahava Berkowitz, Mona Saraiya, Louise Wideroff and Vicki B. Benard

pp. 338-345

  
 


Audit of paired anal cytology and histopathology outcomes in patients referred to a public sexual health clinic 

Vincent M. Williams, Cecily Metcalf, Martyn A. French and Jenny C. McCloskey

pp. 346-351

  
 


A brief history of economic evaluation for human papillomavirus vaccination policy 

Philippe Beutels and Mark Jit

pp. 352-358

  
 


Models of cervical screening in the era of human papillomavirus vaccination 

Karen Canfell

pp. 359-367

  
 


Unresolved questions concerning human papillomavirus infection and transmission: a modelling perspective 

David G. Regan, David J. Philp and Edward K. Waters

pp. 368-375

 


Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era 

Joseph Tota, Salaheddin M. Mahmud, Alex Ferenczy, François Coutlée and Eduardo L. Franco

pp. 376-382

  
 


Global reduction of cervical cancer with human papillomavirus vaccines: insights from the hepatitis B virus vaccine experience 

Margaret E. Heffernan, Suzanne M. Garland and Mark A. Kane

pp. 383-390

  
 


Role of the nurse immuniser in implementing and maintaining the National Human Papillomavirus 'Cervical Cancer' Vaccine rollout through a school-based program in Victoria 

Helen Kent, Margaret E. Heffernan, Julie Silvers, Elya Moore and Suzanne M. Garland

pp. 391-393

  
 


Human papillomavirus (HPV) vaccine acceptance and perceived effectiveness, and HPV infection concern among young New Zealand university students 

Carol Chelimo, Trecia A. Wouldes and Linda D. Cameron

pp. 394-396

  
 



Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine 

Julia M. L. Brotherton, Christopher K. Fairley, Suzanne M. Garland, Dorota Gertig and Marion Saville

pp. 397-398

 |        Open Access Article
 


  
Subscriber Login
Username:
Password:  

Current Issue
Journal Cover
Volume 10 (2)

red arrow Submit Article
blank image
Use the online submission system to send us your paper.

 Advertisement


 
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2013